Scientists move to commercialize new isotope production method

02/22/2012 | Reuters

Researchers at the TRIUMF laboratory in Vancouver, British Columbia, are in talks with several companies, including Cardinal Health, Covidien, GE Healthcare, Lantheus Medical Imaging and Nordion, over the business potential of producing the technetium-99m medical isotope using a cyclotron. The process utilizes molybdenum-100 and eliminates the need for a nuclear reactor.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC